These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45 related articles for article (PubMed ID: 19816071)
1. Detection and prediction of breast cancer using double phase Tc-99m MIBI scintimammography in comparison with MRI. Kim IJ; Kim YK; Kim SJ Onkologie; 2009 Oct; 32(10):556-60. PubMed ID: 19816071 [TBL] [Abstract][Full Text] [Related]
2. Incremental diagnostic value of quantitative analysis of double phase Tc-99m MIBI scintimammography for the detection of primary breast cancer additive to visual analysis. Kim SJ; Kim IJ; Bae YT; Kim YK; Kim DS Breast Cancer Res Treat; 2004 Jan; 83(2):129-38. PubMed ID: 14997043 [TBL] [Abstract][Full Text] [Related]
3. Comparison of early and delayed quantified indices of double-phase (99m)Tc MIBI scintimammography in the detection of primary breast cancer. Kim SJ; Kim IJ; Bae YT; Kim YK; Kim DS Acta Radiol; 2005 Apr; 46(2):148-54. PubMed ID: 15902889 [TBL] [Abstract][Full Text] [Related]
4. Characterization of breast lesion using double phase Tc-99m Tetrofosmin scintimammography: comparison of visual and quantitative analyses. Lee JS; Kim SJ; Kim IJ; Bae YT; Kim YK; Kang YS; Kim DS Eur J Radiol; 2006 Jan; 57(1):76-80. PubMed ID: 16125892 [TBL] [Abstract][Full Text] [Related]
5. Comparison of quantitative and visual analysis of Tc-99m MIBI scintimammography for detection of primary breast cancer. Kim SJ; Kim IJ; Bae YT; Kim YK; Kim DS Eur J Radiol; 2005 Feb; 53(2):192-8. PubMed ID: 15664282 [TBL] [Abstract][Full Text] [Related]
6. Comparison of double phase Tc-99m MIBI and Tc-99m tetrofosmin scintimammography for characterization of breast lesions: Visual and quantitative analyses. Kim IJ; Kim SJ; Kim YK Neoplasma; 2008; 55(6):526-31. PubMed ID: 18999882 [TBL] [Abstract][Full Text] [Related]
7. Complementary role of adjunctive breast magnetic resonance imaging and scintimammography in patients of all ages undergoing breast cancer surgery. Howarth D; Slater S; Lau P; Booker J; Clark D; Sillar R Australas Radiol; 2005 Aug; 49(4):289-97. PubMed ID: 16026435 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of mammographic breast lesions with Tc-99m sestamibi scintimammography and contrast enhanced MRI. Sommer H; Tiling R; Pechmann M; Kindermann G; Kress K; Moser R; Tatsch K; Hahn K; Pfluger T; Assemi C Zentralbl Gynakol; 1997; 119(1):6-11. PubMed ID: 9050197 [TBL] [Abstract][Full Text] [Related]
9. Fusion of magnetic resonance and scintimammography images for breast cancer evaluation: a pilot study. Duarte GM; Cabello C; Torresan RZ; Alvarenga M; Telles GH; Bianchessi ST; Caserta N; Segala SR; de Lima Mda C; Etchebehere EC; Camargo EE; Tinois E Ann Surg Oncol; 2007 Oct; 14(10):2903-10. PubMed ID: 17632758 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic performances of double-phase tc-99m MIBI scintimammography in patients with indeterminate ultrasound findings: visual and quantitative analyses. Kim SJ; Bae YT; Lee JS; Kim IJ; Kim YK Ann Nucl Med; 2007 Jun; 21(3):145-50. PubMed ID: 17561585 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of (99m)Tc-3PRGD2 scintimammography for differentiation of malignant from benign breast lesions: Comparison of visual and semi-quantitative analysis. Chen Q; Xie Q; Zhao M; Chen B; Gao S; Zhang H; Xing H; Ma Q Hell J Nucl Med; 2015; 18(3):193-8. PubMed ID: 26574690 [TBL] [Abstract][Full Text] [Related]
12. Scintimammography with 99mTc-MIBI and magnetic resonance imaging in the evaluation of breast cancer. Bagni B; Franceschetto A; Casolo A; De Santis M; Bagni I; Pansini F; Di Leo C Eur J Nucl Med Mol Imaging; 2003 Oct; 30(10):1383-8. PubMed ID: 12910383 [TBL] [Abstract][Full Text] [Related]
13. 99mTc-3P4-RGD2 scintimammography in the assessment of breast lesions: comparative study with 99mTc-MIBI. Ma Q; Chen B; Gao S; Ji T; Wen Q; Song Y; Zhu L; Xu Z; Liu L PLoS One; 2014; 9(9):e108349. PubMed ID: 25250628 [TBL] [Abstract][Full Text] [Related]
14. Dual phase qualitative and quantitative 99mTc-MIBI scintimammography for predicting response to neoadjuvant chemotherapy in breast cancer. Zaman MU; Nasir Z; Raza T; Hashmi H; Hashmi A; Fatima N J Coll Physicians Surg Pak; 2009 Mar; 19(3):173-8. PubMed ID: 19268018 [TBL] [Abstract][Full Text] [Related]
15. Scintimammography with technetium-99m methoxyisobutylisonitrile: comparison with mammography and magnetic resonance imaging. Palmedo H; Grünwald F; Bender H; Schomburg A; Mallmann P; Krebs D; Biersack HJ Eur J Nucl Med; 1996 Aug; 23(8):940-6. PubMed ID: 8753683 [TBL] [Abstract][Full Text] [Related]
16. Prediction of the usefulness of combined mammography and scintimammography in suspected primary breast cancer using ROC curves. Buscombe JR; Cwikla JB; Holloway B; Hilson AJ J Nucl Med; 2001 Jan; 42(1):3-8. PubMed ID: 11197976 [TBL] [Abstract][Full Text] [Related]
17. Role of technetium-99m sestamibi scintimammography and contrast-enhanced magnetic resonance imaging for the evaluation of indeterminate mammograms. Tiling R; Khalkhali I; Sommer H; Moser R; Meyer G; Willemsen F; Pfluger T; Tatsch K; Hahn K Eur J Nucl Med; 1997 Oct; 24(10):1221-9. PubMed ID: 9323262 [TBL] [Abstract][Full Text] [Related]
18. The value of early and double phase 99Tcm-sestamibi scintimammography in the diagnosis of breast cancer. Paz A; Melloul M; Cytron S; Koren R; Ohana G; Michalevich D; Gal R; Wolloch Y Nucl Med Commun; 2000 Apr; 21(4):341-8. PubMed ID: 10845222 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of mammography and scintimammography in detection of primary breast cancer related size of the tumour. Cwikła JB; Buscombe JR; Chaberek S; Holloway B; Parbhoo S; Hilson AJ Nucl Med Rev Cent East Eur; 2000; 3(2):127-32. PubMed ID: 14600905 [TBL] [Abstract][Full Text] [Related]
20. Initial evaluation of breast cancer using Tc-99m sestamibi scintimammography. Tiling R; Kessler M; Untch M; Sommer H; Linke R; Hahn K Eur J Radiol; 2005 Feb; 53(2):206-12. PubMed ID: 15664284 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]